SEC Form 4/A · accession 0000878526-16-000140
NATUS MEDICAL INC · BABY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Kenneth M Traverso
Officer — VP/GM Newborn Care
Period of report
Apr 22, 2016
Accepted (ET)
Apr 28, 2016 · 8:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000878526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share | Apr 22, 2016 | M | 7,459 | $16.78 | A | 112,119 | D | |
| Common Stock, $0.001 par value per shareF1,F2 | Apr 22, 2016 | S | 7,459 | $33.56 | D | 104,660 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonqualified Stock Option | $16.78 | Apr 22, 2016 | M | 7,459 | D | Jul 3, 2010 | Jun 3, 2016 | Common Stock | 7,459 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $33.46 to $33.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This form corrects the price information in the footnote that was previously filed.